Evidence map›Paper›PMID 34710102›Full record

ArticlePloS one2021

How faculty define quality, prestige, and impact of academic journals.

Esteban Morales, Erin C McKiernan, Meredith T Niles, Lesley Schimanski, Juan Pablo Alperin

Abstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Shifting the Level of Selection in Science.Perspectives on psychological science : a journal of the Association for Psychological Science · 2024
    Article
  8. Article
  9. Designing a Framework for Evaluating the Scientific Productions.International journal of preventive medicine · 2024
    Article
  10. BJA open · 2022
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Esteban MoralesUniversity of British Columbia, Vancouver, Canada.
Erin C McKiernanUniversidad Nacional Autónoma de México, Mexico City, Mexico.
Meredith T NilesUniversity of Vermont, Burlington, Vermont.
Lesley SchimanskiSimon Fraser University, Burnaby, Canada.
Juan Pablo AlperinSimon Fraser University, Burnaby, Canada.ORCID 0000-0002-9344-7439

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite the calls for change, there is significant consensus that when it comes to evaluating publications, review, promotion, and tenure processes should aim to reward research that is of high "quality," is published in "prestigious" journals, and has an "impact." Nevertheless, such terms are highly subjective and present challenges to ascertain precisely what such research looks like. Accordingly, this article responds to the question: how do faculty from universities in the United States and Canada define the terms quality, prestige, and impact of academic journals? We address this question by surveying 338 faculty members from 55 different institutions in the U.S. and Canada. While relying on self-reported definitions that are not linked to their behavior, this study's findings highlight that faculty often describe these distinct terms in overlapping ways. Additionally, results show that marked variance in definitions across faculty does not correspond to demographic characteristics. This study's results highlight the subjectivity of common research terms and the importance of implementing evaluation regimes that do not rely on ill-defined concepts and may be context specific.

Indexed as

FacultyJournal Impact FactorCanadaCareer MobilityHumansPeer ReviewPeriodicals as TopicUnited StatesUniversities

Identifiers

PMID34710102
PMCPMC8553056

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.